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Contact sensitivity to dinitro-fluorobenzene in the 
mouse is a form of delayed-type hypersensitivity. This 
reaction is closely regulated. Tolerance to contact sen-
sitivity is mediated by at least 2 mechanisms, tolerance 
without demonstrable suppressor cells and tolerance 
with suppressor T cells. Suppressor T cells can inhibit 
either the afferent limb of sensitization or the efferent 
(elicitation) phase. These cells probably operate via sol-
uble suppressor factors and require auxiliary cells. The 
duration of contact sensitivity itself is controlled by 
another mechanism, which is antibody. This antibody is 
directed against the T cells responsible for the delayed 
hypersensitivity state (Tm~), and down-regulate these 
cells. It is antigen-specific and has the properties of an 
antireceptor (anti-idiotypic) antibody. 
This paper will summarize om experience with the regulation 
of contact sensitivity in the mouse. We have studied this model 
extensively over the past few years. It seemed to be a simple 
and straightforward system at first, but fuxther experimental 
results have shown that it is indeed very complex. Even now 
we do not understand the complete regulatory system. So far, 
however, we have uncovered a variety of mechanisms for mod-
ulating the response. These include 2 kinds of suppressor cells, 
a suppressor auxiliary cell, an antireceptor antibody and a state 
of tolerance without demonstrable suppressor mechanisms. 
I. CONTACT SENSITIZATION TO 
DINITROFLUOROBENZENE (DNFB) IN THE MOUSE 
Contact sensitization to DNFB is easily induced in most 
(perhaps all) strains of mice by simply painting a solution of 
DNFB on the abdomen [1]. This activates the afferent limb of 
the response. The existence of the sensitized state can be shown 
by challenging the animal with another dose of (dilute) DNFB, 
thereby activating the efferent limb. This is done by applying 
DNFB to the ears and measuring ear swelling 24 hr later with 
a micrometer. 
This response has the following charaCteristics. It is: 
1. antigen specific 
2. delayed in t ime (peak ear swelling is at 24h.r) 
3. not accompanied by serum anti-DNP antibodies (which 
may occm if more vigorous or prolonged sensitization is 
used) [2] 
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4. transferred to syngeneic recipients with T cells, not with 
serum 
5. not produced in T -deprived mice 
6. not accompanied by basophilic infiltrations. 
Therefore, it appears to be as classic a case of delayed type 
hypersensitivity as that seen with TNCB (picryl chloride) in 
the guinea pig. It does differ, however, in at least one respect in 
that sensitivity wanes rapidly with time. In our hands, peak 
sensitivity occurs 5 days after sensitization and has almost 
disappeared by 13 days. 
II. TOLERANCE TO CONTACT SENSITIVITY 
A very large number of experiments have been done to induce 
tolerance to contact sensitivity prior to sensitization (reviewed 
in reference 3). Tolerance to DNFB in mice can be induced by 
an i.v. injection of DNBSOJ. This tolerance is specific and long-
lasting. An interesting feature is that tolerance takes time to 
develop after DNBSOJ injection. While only about 30% unre-
sponsiveness is seen 1-2 days after DNBS03 injection, a week 
later the mice are virtually completely tolerant [ 4]. A series of 
experiments then showed that the ability of a group of DNP 
congeners to tolerize was proportional to their ability to bind 
protein. This indicated that tolerance, like contact sensitivity 
itself, was probably mediated by DNP-protein conjugates 
[5,6]. As DNP-mouse gamma-globulin (a potent B cell tolero-
gen) did not induce tolerance to contact sensitization, it ap-
peared likely that the "real" tolerogen formed in vivo after 
DNBS03 administration was DNP-membrane. Indeed, DNP 
coupled to syngeneic (or allogeneic) cells in vitro was a more 
powerful tolerogen than DNBS03 or free DNFB. Furthermore, 
DNP-LC (DNP-lymphoid cells), unlike DNBS03, induced max-
imum tolerance immediately [7]. 
Analysis of these various features have uncovered several 
mechanisms of immunoregulation of contact allergy. 
III. TOLERANCE WITHOUT SUPPRESSORS 
Tolerance mediated via suppressive mechanisms will be dis-
cussed in detail later on in this paper. Nevertheless, we and our 
colleagues believe that significant tolerance can occur without 
suppressive mechanisms, and that this nonsuppressor pathway 
may indeed be the mo t important one. 
The evidence that tolerance can occur in the absence of 
suppressor mechanisms comes from the following observations: 
1. Tolerance can be induced "in1mediately" with DNP-LC 
while suppressor cells require time to develop. 
2. Such "instant" tolerance cannot be transferred adoptively 
(as suppressor cells can), and mice "instantly" tolerized cannot 
suppress sensitized immigrant cells, in a reverse adoptive trans-
fer [7). 
3. Situations known to inhibit development of suppressor 
cell systems, e.g., splenectomy, or prior treatment with cyclo-
phosphamide, do not abrogate this state of tolerance [8]. 
We envisage this state of tolerance to be one in which the 
tolerogen (DNP-LC) directly encounters the T cell (ToH) re-
sponsible for contact sensitivity to DNFB and thereby inacti-
vates it. We do not know if this occw-s via blockade of the 
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receptors of that Tm1 or via some type of clone deletion. To 
cover both possibilities we have used the rather vague term, 
"clone inhibition." It is possible that this state of clone inhibi-
tion involves a pathway which bypasses the usually immuno-
genic route of antigen presentation which is stimulatory for 
ToH - This immunogenic route probably involves macrophage 
interaction with the antigen. It is significant that tolerization of 
ToH requires the intravenous route for the DNP-LC tolerogen, 
while subcutaneous innoculation of the some material leads not 
to tolerance but to sensitization [9]. It is also significant that 
the genetic requirements for tolerization are very similar to 
those for sensitization. That is, in animals syngeneic at the K 
and D ends of the major histocompatibility locus (MHC) effi-
cient tolerance is induced with DNP-cells which are compatible 
with the recipient at the I region. 1-region incompatible cells do 
not tolerize [10]. Furthermore, if one compares various DNP-
cell preparations, the degree of tolerogenicity varies directly 
with the content of !-region gene products on the haptenated 
cell populations (unpublished). As T cells best "see" antigens 
in the context of !-region determinants when activation is 
concerned, it is quite logical to believe that the same is true 
when one is considering tolerance by clone inhibition-provided 
the tolerogen evades the "immunogenic route." 
A warning is necessary here. It is a good scientific rule-of-
thumb to recognize that "absence of proof is not the same as 
proof of absence." Although we have results in which we find 
tolerance without suppressors, it is possible that they are there 
but undetecte~ or unTecognized. We are continuing our search. 
IV. TOLERANCE WITH SUPPRESSORS 
Asherson and his colleagues showed that suppressor cells of 
T cell origin (Ts) were important in tolerance to contact sensi-
tivity [11] and we reported similar findings at these Brook 
Lodge meetings in 1974 [12]. Further analysis of these Ts has 
proven very interesting. 
Ts are only demonstrable for about 10 days after tolerization, 
yet tolerance lasts for 1-2 mo [5]. This is one of the reasons 
that we believe that Ts play only an incomplete role in the 
maintenance of tolerance and that clone inhibition occurs be-
fore and persists after Ts are found. 
Additional complexity arises when one considers the results 
of the injection of DNP-syngeneic vs. DNP-allogeneic cells. In 
the case of the BALB/c mouse which we use "instant" toler-
ance occurs after the injection of either DNP-BALB/c-LC or 
of DNP-CBA-LC. In each case, Ts are demonstrable a week 
later. There are significant differences between the Ts induced 
in these cases. 
1. Ts-eff (Ts Suppressing the Efferent Limb) 
These Ts are induced by injection ofDNP-LC into syngeneic 
mice. These Ts are defined by their ability to inhibit the 
efferent (elicitation) limb of the contact sensitivity response. 
Operationally, they are assayed by the fact that they depress 
the passive transfer of contact sensitivity when given together 
with ToH from sensitized donors into naive recipients (Lanstei-
ner-Chase type passive transfer). These Ts-eff do not inhibit 
the afferent limb of contact sensitivity. Thus, when given alone 
to a naive recipient, they do not inhibit the ability of that 
animal to develop To1-1 when painted on the abdomen with 
DNFB. Rather, they inhibit the expression of the To1-1; thus, 
the animal appears suppressed [13]. 
The genetic restrictions on the action of Ts-eff require com-
ment. At first we found that Ts-eff induced in BALBI c mice by 
injection of DNP-BALB/c mice by injection of DNP-BALB/c-
LC were genetically unrestricted. That is, they would inhibit 
the passive transfer of ToH from BALB/c or CBA or C57Bl/6 
(or presumably any other strain of) mice [13]. This kind of data 
is compatible with the idea that Ts-eff "see" an MHC product 
of public specificity or perhaps see no MHC product at all, only 
DNP. 
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FuTther analysis of the phenomenon showed that the Ts so 
raised in BALB/c mice were really a polyclonal collection of 
Ts, each specific for DNP in conjunction with a specific MHC 
haplotype. This finding was determined by asking what DNP-
congeners were capable of inhibiting Ts-eff from suppressing 
T01-1· We have shown that DNP-lysine, and heavily haptenated 
DNP-protein conjugates were incapable of "blocking" Ts func-
tion. Thus, Ts-eff do not appear to "see" hapten alone. When 
we made soluble membrane preparations from DNP-LC and 
tested them for their ability to block Ts-eff, several very inter-
esting results were found. In terms of suppression of syngeneic 
TDJ-1, the suppressive action of Ts-eff was only blocked by 
pretreatment with soluble syngeneic DNP-LC membrane prep-
arations, and not by syngeneic TNP-LC membranes [14]. 
Further experiments showed that inhibition of syngeneic 
suppression could be achieved by DNP-modified-membrane 
preparations that were only H-2D-region compatible with the 
Ts donors. Thus, Ts antigen receptors in this system specifically 
recognize DNP-modified H-2D-region determinants. In con-
trast, we found that pretreatment of syninduced Ts with syn-
geneic DNP-LC membranes did not inhibit the ability to sup-
press allogeneic ToH- However, pretreatment of Ts with DNP-
allogeneic membrane which were H-2D-end compatible to the 
allogeneic target ToH eliminated their ability to suppress the 
specific allogeneic T 0 1-1, leaving intact suppression of syngeneic 
or third party T 0 1-1. We propose that pertubation ofthe immune 
system by intravenous injection of syngeneic DNP-LC leads to 
the induction of a polyclonal wave of DNP-specific Ts activity. 
Some members of this set of Ts rcognize DNP-self MHC 
determinants with moderate affinity and are thus specifically 
inhibited after pretreatment with those DNP-self determinants. 
Other members of this set display receptors which cross-react 
with high affinity with DNP-allogeneic determinants and thus 
suppress allogeneic T01-1 cells. These allosuppressive clones can 
thus be specifically inhibited only by pretreatment with DNP-
LC membranes, MHC-compatible with the target ToH [14]. 
These newer findings are more in accord with our previous 
findings that T suppressors in contact sensitivity rcognize DNP 
in conjunction with the H-2D region of the MHC [15]. 
Recent evidence (manuscript in preparation) also points to 
the importance of epitope density of hapten on the DNP-LC 
used as tolerogen on the MHC restrictions of the Ts-eff which 
are generated. Our normal labelling concentration, as described 
above, leads to polyclonal Ts which are induced by and recog-
nize DNP-modified H-2D-end determinants. Lowering the con-
centration of DNFB used to modify the lymphoid cells by a 
factor of 100, leads to a MHC-restricted population ofTs which 
are induced by and recognize DNP-modified H-2K and/or H-
2D-end determinants. 
2. Ts-eff Require Ts-aux 
Recent experiments show that Ts-eff cannot inhibit ToH 
alone, but that another antigen-specific T cell is needed. This 
cell, called an auxiliary T suppressor (Ts-aux), arises in sensi-
tized mice together with To1-1. Together, ToH and Ts-aux pro-
vide a suitable target for the suppressive potency of Ts-eff [16] 
. The mode of interaction of these three cells, and/or their 
products, is not known. 
3. Ts-aff (Ts Suppressing the Afferent Limb) 
These Ts are induced by injection of DNP-allogeneic cells, 
e.g., DNP-CBA-LC into BALB/c mice. These Ts are defined 
by their ability to inhibit the afferent (sensitization) ljmb of the 
contact sensitivity response. Operationally, they are assayed by 
the fact that they depress the ability of naive animals to develop 
contact sensitivity when sensitized with DNFB epicutaneously. 
These Ts-aff do not inhibit the efferent limb, i.e., they do not 
inhibit the ability of To1-1 from sensitized mice to passively 
transfer sensitivity to normal recipients. Furthermore, unlike 
Ts-eff, these Ts-aff are genetically restricted. That is, Ts-aff 
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induced in BALB/c mice by injection of DNP-CBA LC can 
only inhibit the development of contact sensitivity in mice 
which share the H-2D haplotype of the tolerogen, in this case 
H-2Dk [17]. It should be noted that the Ts induced by DNBSOa 
are also Ts-aff [18]. 
V. NEGATIVE IMMUNOREGULATION BY ANTI-
RECEPTOR ANTIBODY 
Again, as shown by Asherson and colleagues, contact sensi-
tivity can be regulated by B cells [19]. We mentioned above 
that contact sensitivity to DNFB in mice wanes with time after 
reaching its apogee at 5 days after sensitization. It now appears 
that the waning of sensitization occurs via the mediation of a 
specific antibody which appea1·s in the serum about 9 days after 
epicutaneous painting. This serum can suppress the passive 
transfer of sensitivity to DNFB when cotrimsferred to naive 
recipients together with ToH from sensitized donors. The sup-
pressive activity of the serum is antigen-specific but the serum 
has no anti-DNP properties. Rather, it is adsorbed by ToH from 
DNFB-sensitized mice [20]. For this reason, we believe it is a 
true antireceptor antibody induced by and directed against 
specific ToH- Thus, it is a perfect vehicle for specifically limiting 
the duration, and perhaps, the magnitude of the contact sensi-
tivity response. 
VL REGULATORY SOLUBLE FACTORS IN CONTACT 
SENSITIVITY 
Soluble suppressor factors (SSF) have been isolated in this 
same model of contact sensitivity and tolerance to DNFB. 
Detailed discussion of these is beyond the scope of this paper, 
but we should mention that one of these factors is antigen-
specific, and inhibits the efferent limb of the immune response 
[21]. This SSF has affinity for antigen and is a product of the 
MHC. It is unusual in that it requires identity (between the 
producer and the target) at either the H-2K or H-2D end of the 
MHC [22]. The precise relation between this SSF and the Ts 
mentioned above is under study. 
SUMMARY 
The Figure shows a summary diagram of suppressor T cells 
and antireceptor antibody in the control of contact sensitivity. 
(Clone inhibition and soluble suppressor factor are not shown.) 
It is apparent that the seemingly simple model of contact 
allergy to DNFB can be controlled at several points and by 
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several mechanisms. The detailed targets of control and the 
means by which controls are exerted are still being investigated. 
We thank Ms. Kathy Utschinski for typing this manuscript. 
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DISCUSSION 
SHEVACH: Do you think that any cell preparation that is haptenated 
and injected intravenously would be capable of inducing immunity? 
CLAMAN: Instant tolerance is produced by haptenated Ia positive 
cells given intravenously; haptenated red cells will produce tolerance 
but it takes 4 or 5 days. We have never seen a cell preparation given 
LV. which has immunity. We have seen some that have failed to induce 
tolerance. 
SHEVACH: W. Ptak and R. Gershon have recently shown that hap-
tenated skin cells injected LV. induce contact sensitivity rather than 
tolerance. The cell which induces immuni ty is FC+ and is probably a 
Langerhans cell. 
CLAMAN: What you get depends upon what you inject and by what 
route. It has been shown by Benacerrars group, with hapten, and by 
our group with protein coupled to cells that if you inject intravenously 
you get tolerance and if you inject subcutaneously you get immunity. 
So the route becomes important. The carrier is obviously important; 
things like haptenated red cells and haptenated Ia posit ive cells tolerize 
and, therefore, you might expect that you could inj ect something else 
haptenated that would produce contact sensitivi ty. The fate of the 
injected cells is also obviously important. 
GREEN: It should be pointed out that Sulzberger and Chase, about 
40 or 50 years ago, showed that if you feed these reactive hap tens, you 
also get tolerance. I wonder whether your phenomenon is closely 
related to theirs? (Their administration was through the gastro- intes-
Vol. 74, No. 5 
tina! tract, which at one time was felt to be very important.) 
CLAMAN: Hanson and also Chiller have shown that feeding proteins 
induces tolerance by clone inhibition and/or anti-idiotypic antibodies. 
These experiments are very similar to the Merrill Chase experiments 
in feeding picryl chloride. Again, what you get depends upon how you 
give it. Paint it on the skin and the animals become sensitized. Feed it 
a nd they become tolerant. Give it intravenously and they become 
tolerant. 
STREILEIN: Is the serum that inhibits Tdh cells in vivo a typical 
hyperimmune anti-DNP serum, or is it a "special" serum raised by the 
tolerizing protocol? 
CLAMAN: That serum is induced during sensitization, not dw·ing 
tolerance. It is the serum of an animal that has been painted 10 days 
before. 
STRE!LEIN: So you don't really know whether there might be some-
thing special, some special subclass, say of immunoglobin, you have 
induced by this method. 
CLAMEN: We don't know what the class of immunoglobu lin is, but 
the point is that the se1·um from a normally pa inted animal 10 days 
later contains an antigen-specific suppressor substance which sup-
presses the animal's own TDH cells. 
KATZ: Can you passively transfer sensitized cells into those which 
have "instant" tolerance? I would assume you can. 
CLAMAN: The a nswer is yes. Tha t was the reverse passive transfer 
experiment I mentioned which we used as additional evidence to show 
that there were no t suppressor cells. 
